Distributor Charles Tennant explains how Macrophi’s lipopolysaccharides ingredient - amphiphilic glycolipids derived from gram-negative bacteria - supports key skin functions such as barrier reinforcement, hydration, and epidermal renewal.
As consumer awareness of the skin's immune function grows, cosmetic science is increasingly exploring biologically active compounds that go beyond superficial hydration or anti-ageing claims. One such emerging ingredient class is lipopolysaccharides (LPS), amphiphilic glycolipids derived from gram-negative bacteria.
Traditionally studied for their role in immunology and gut health, LPS are now being positioned as powerful actives for dermocosmetic applications, particularly for their ability to promote a healthy skin microbiome.
Macrophi Inc. is a company grounded in macrophage biology and a pioneer in innate immunity research. Its LPS technology offers a new path for formulators seeking clinically relevant, immune-supporting actives.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
